Product NDC: | 0555-0779 |
Proprietary Name: | Medroxyprogesterone Acetate |
Non Proprietary Name: | Medroxyprogesterone Acetate |
Active Ingredient(s): | 10 mg/1 & nbsp; Medroxyprogesterone Acetate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0555-0779 |
Labeler Name: | Barr Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040159 |
Marketing Category: | ANDA |
Start Marketing Date: | 19961204 |
Package NDC: | 0555-0779-04 |
Package Description: | 500 TABLET in 1 BOTTLE (0555-0779-04) |
NDC Code | 0555-0779-04 |
Proprietary Name | Medroxyprogesterone Acetate |
Package Description | 500 TABLET in 1 BOTTLE (0555-0779-04) |
Product NDC | 0555-0779 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Medroxyprogesterone Acetate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19961204 |
Marketing Category Name | ANDA |
Labeler Name | Barr Laboratories Inc. |
Substance Name | MEDROXYPROGESTERONE ACETATE |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |